202 related articles for article (PubMed ID: 17102040)
41. Primovist, Eovist: what to expect?
Van Beers BE; Pastor CM; Hussain HK
J Hepatol; 2012 Aug; 57(2):421-9. PubMed ID: 22504332
[TBL] [Abstract][Full Text] [Related]
42. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
[TBL] [Abstract][Full Text] [Related]
43. [VIBE with parallel acquisition technique - a novel approach to dynamic contrast-enhanced MR imaging of the liver].
Dobritz M; Radkow T; Nittka M; Bautz W; Fellner FA
Rofo; 2002 Jun; 174(6):738-41. PubMed ID: 12063604
[TBL] [Abstract][Full Text] [Related]
44. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
[TBL] [Abstract][Full Text] [Related]
45. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine.
Filippone A; Blakeborough A; Breuer J; Grazioli L; Gschwend S; Hammerstingl R; Heinz-Peer G; Kittner T; Laghi A; Leen E; Lencioni R; Lucidarme O; Remplik P; Robinson PJ; Ruehm SG; Schaefer F; Stoupis C; Tombach B; Valette PJ; Zech CJ; Huppertz A
J Magn Reson Imaging; 2010 Feb; 31(2):356-64. PubMed ID: 20099349
[TBL] [Abstract][Full Text] [Related]
47. Technique for MR imaging of the liver.
Saini S; Nelson RC
Radiology; 1995 Dec; 197(3):575-7. PubMed ID: 7480718
[No Abstract] [Full Text] [Related]
48. Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: an overview of preclinical animal experiments.
Ni Y; Marchal G
Top Magn Reson Imaging; 1998 Jun; 9(3):183-95. PubMed ID: 9621406
[TBL] [Abstract][Full Text] [Related]
49. Contrast agents for MR imaging of the liver: a clinical overview.
Mahfouz AE; Hamm B; Taupitz M
Eur Radiol; 1997; 7(4):507-13. PubMed ID: 9204329
[TBL] [Abstract][Full Text] [Related]
50. MR imaging of the gallbladder: a pictorial essay.
Catalano OA; Sahani DV; Kalva SP; Cushing MS; Hahn PF; Brown JJ; Edelman RR
Radiographics; 2008; 28(1):135-55; quiz 324. PubMed ID: 18203935
[TBL] [Abstract][Full Text] [Related]
51. MRI of the liver: choosing the right contrast agent.
Welle CL; Guglielmo FF; Venkatesh SK
Abdom Radiol (NY); 2020 Feb; 45(2):384-392. PubMed ID: 31392396
[TBL] [Abstract][Full Text] [Related]
52. New directions in the development of MR imaging contrast media.
Brasch RC
Radiology; 1992 Apr; 183(1):1-11. PubMed ID: 1549653
[TBL] [Abstract][Full Text] [Related]
53. Perfusion imaging in liver MRI.
Thng CH; Koh TS; Collins D; Koh DM
Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):417-32. PubMed ID: 25086937
[TBL] [Abstract][Full Text] [Related]
54. Contrast-enhanced magnetic resonance body imaging 5.
Schneider G; Uder M
Top Magn Reson Imaging; 2003 Oct; 14(5):403-25. PubMed ID: 14625468
[TBL] [Abstract][Full Text] [Related]
55. Contrast Agents for MR Imaging.
Czeyda-Pommersheim F; Martin DR; Costello JR; Kalb B
Magn Reson Imaging Clin N Am; 2017 Nov; 25(4):705-711. PubMed ID: 28964460
[TBL] [Abstract][Full Text] [Related]
56. Re: MR urographic techniques.
Buckley O; Colville J; Torreggiani WC; Leyendecker JR
Radiographics; 2008; 28(3):907; author reply 907-8. PubMed ID: 18480492
[No Abstract] [Full Text] [Related]
57. Intravenous gadolinium-based hepatocyte-specific contrast agents (HSCAs) for contrast-enhanced liver magnetic resonance imaging in pediatric patients: what the radiologist should know.
Ayyala RS; Anupindi SA; Gee MS; Trout AT; Callahan MJ
Pediatr Radiol; 2019 Sep; 49(10):1256-1268. PubMed ID: 31350632
[TBL] [Abstract][Full Text] [Related]
58. Gaucher disease in the liver on hepatocyte specific contrast agent enhanced MR imaging.
Ayyala RS; Teot LA; Perez Rossello JM
Pediatr Radiol; 2017 Apr; 47(4):484-487. PubMed ID: 28144704
[TBL] [Abstract][Full Text] [Related]
59. Advocating the Development of Next-Generation High-Relaxivity Gadolinium Chelates for Clinical Magnetic Resonance.
Runge VM; Heverhagen JT
Invest Radiol; 2018 Jul; 53(7):381-389. PubMed ID: 29462023
[TBL] [Abstract][Full Text] [Related]
60. Magnetic Resonance Imaging of the Liver (Including Biliary Contrast Agents) Part 1: Technical Considerations and Contrast Materials.
Agostini A; Kircher MF; Do R; Borgheresi A; Monti S; Giovagnoni A; Mannelli L
Semin Roentgenol; 2016 Oct; 51(4):308-316. PubMed ID: 27743567
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
